Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Breast Tomosynthesis Can Rule Out Cancer Without Additional Scan

By MedImaging International staff writers
Posted on 22 Mar 2011
The first commercially available breast cancer screening and diagnosis system provides the potential of breast tomosynthesis, a cutting-edge technology poised to transform how breast cancer is currently detected.

Hologic, Inc. More...
(Bedford, MA, USA), a developer, manufacturer, and supplier of diagnostics products, medical imaging systems and surgical products focused on serving the healthcare needs of women, showcased the Selenia Dimensions three-dimensional (3D) mammography and other new, ready-to-market technologies in women's imaging at the 21st annual US National Interdisciplinary Breast Center Conference (NCBC) in Las Vegas, NV, USA, March 12-16, 2011. The NCBC is a nonprofit membership organization dedicated to excellence in breast healthcare for the public.

Mammography systems using traditional 2D imaging have limitations caused by tissue overlapping, tissue in the breast that may hide lesions, or cause benign areas to appear suspicious. In clinical studies, radiologists reading 2D plus 3D mammography (breast tomosynthesis) compared to 2D mammography alone demonstrated superior clinical performance in specificity, the confidence to rule out breast cancer without recalling the patient for additional study, and also demonstrated improved sensitivity, the proportion of mammograms that include breast cancers that were correctly diagnosed.

Hologic's Selenia Dimensions systems are installed in more than a dozen countries and cleared for sale in 40 countries. Selenia Dimensions 3D was approved for sale in the United States by the US Food and Drug Administration (FDA) on February 11, 2011.

Selenia Dimensions provides the exceptional 2D images the industry has come to expect from Hologic and, for the first time ever, gives radiologists the option of offering their patients a conventional 2D digital mammogram and a 3D tomosynthesis exam all under one compression, in just seconds, at a combined X-ray dose below the FDA's acceptable maximum guidelines for screening mammography.

Also shown for the first time at NCBC are two new products designed specifically for our Selenia Dimensions 2D/3D system: the Affirm upright breast biopsy-guidance system and ImageChecker 3D Calc computer-aided detection (CAD). Affirm is cleared for sale in the United States. ImageChecker 3D Calc is a work in progress and is not available for sale in the United States.

Related Links:

Hologic




Diagnostic Ultrasound System
DC-80A
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Ultrasonic Pocket Doppler
SD1
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.